Target intelligence / Profile preview

Immunoglobulin heavy variable 3-48 (IGHV3-48)

Target
IGHV3-48
Molecular classification
Other (immunoglobulin variable region gene segment)
01

Overview

Immunoglobulin heavy variable 3-48 is a gene segment that encodes the variable (V) region of the immunoglobulin heavy chain in B cells[2][3][5][7]. The V region forms part of the antigen-binding site of antibodies and is responsible for specific recognition of antigens, working together with different light chain variable regions. This gene segment is part of the complex immunoglobulin genomic locus on chromosome 14 and contributes to the remarkable diversity of antibodies produced by the human immune system through V(D)J recombination[1][5]. The product of IGHV3-48 itself is not a therapeutic target but is a structural genetic component used by lymphocytes to generate the diversity of the antibody repertoire[2][3][4][7]. IGHV3-48 does not function as a receptor, enzyme, transporter, or other drug target in isolation and therefore is not considered a therapeutic target nor directly interacts with drugs; its expression is instead essential for the adaptive immune response and antibody-mediated immunity[1][2][3][4].

Other names
IGHV3-48Ig heavy chain V-III region WEAIGHV348VHIGHV3-48 gene segment
02

Biological functions

Antigen recognitionImmune response (through antigen binding as part of immunoglobulin)
03

Disease associations

Other (variable regions like IGHV3-48 can be involved in autoimmune disease, infection response, or B-cell malignancies only as part of antibodies, not as standalone targets)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-48 (IGHV3-48).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-48 (IGHV3-48).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call